FDA Inspection 1064555 — Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
The FDA completed an inspection of Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. on July 26, 2018 in Changzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 26, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changzhou (China)